FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2922257911> ?p ?o ?g. }

• W2922257911 endingPage "296" @default.
• W2922257911 startingPage "290" @default.
• W2922257911 abstract "Background/Aims Obtaining ethical approval from multiple institutional review boards is a long-standing challenge to multi-site clinical trials and often leads to significant delays in study activation and enrollment. As of 25 January 2018, the National Institutes of Health began requiring use of a single institutional review board for US multi-site trials. To learn more and further inform the research and regulatory communities around aspects of transitioning to single institutional review board review, this study evaluated the efficiency, resource use, and user perceptions of a nascent institutional review board reliance model (Streamlined, Multi-site, Accelerated Resources for Trials IRB Reliance). Methods This research was embedded within the Influenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure trial—a multi-site trial of two influenza vaccine formulations. In the first year of the trial, a sample of sites agreed to use the developing Streamlined, Multi-site, Accelerated Resources for Trials IRB Reliance model and participated in its evaluation. In keeping with a least burdensome approach, short surveys were developed and obtained from each reporting entity (relying sites, non-relying site, lead site, and reviewing institutional review board). Data regarding time to institutional review board approval and site activation, costs, and user perceptions of reliant review were self-reported and collected via the survey form. Quantitative and qualitative analyses were performed, with costs analyzed as actual versus estimated due to the lack of established baseline cost data. Results A total of 13 sites ceded review and received institutional review board approval. Mean time to approval was substantially faster in sites that ceded review using the Streamlined, Multi-site, Accelerated Resources for Trials IRB Reliance model versus the site that did not cede review (81 vs 121 days). The mean time to approval was also faster than published averages for academic medical centers (81 vs 103 days). Time to first enrollment was faster for ceding sites versus the non-ceding site, and also faster than published averages (126 vs 149 and 169 days, respectively). Costs were higher than estimates for local institutional review board review and approval. Nearly half (47%) the stakeholders reported being very satisfied or satisfied with the reliance experience, although many noted the challenge related to institutional culture change. Conclusion Implementation of a single institutional review board represents a shift in practice and culture for many institutions. Evaluation of the reliance arrangements for this study highlights both the potential of, and challenges for, institutions as they transition to single institutional review board review. Although efficiencies were observed for study start-up, we anticipate a learning curve as institutions and research teams implement necessary process and resource changes to adapt to single institutional review board oversight. Findings may inform research teams but are, however, limited by the relatively small number of sites and lack of a control group." @default.
• W2922257911 created "2019-03-22" @default.
• W2922257911 creator A5001066639 @default.
• W2922257911 creator A5012849300 @default.
• W2922257911 creator A5015556779 @default.
• W2922257911 creator A5040817479 @default.
• W2922257911 creator A5043647925 @default.
• W2922257911 creator A5061256789 @default.
• W2922257911 creator A5062178801 @default.
• W2922257911 creator A5062622461 @default.
• W2922257911 date "2019-03-13" @default.
• W2922257911 modified "2023-10-02" @default.
• W2922257911 title "Transitioning to the National Institutes of Health single institutional review board model: Piloting the use of the Streamlined, Multi-site, Accelerated Resources for Trials IRB Reliance" @default.
• W2922257911 cites W1978269422 @default.
• W2922257911 cites W2044317520 @default.
• W2922257911 cites W2228475140 @default.
• W2922257911 cites W2327735154 @default.
• W2922257911 cites W2563549215 @default.
• W2922257911 cites W2594280119 @default.
• W2922257911 cites W2730133581 @default.
• W2922257911 cites W2731129638 @default.
• W2922257911 doi "https://doi.org/10.1177/1740774519832911" @default.
• W2922257911 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7924135" @default.
• W2922257911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30866676" @default.
• W2922257911 hasPublicationYear "2019" @default.
• W2922257911 type Work @default.
• W2922257911 sameAs 2922257911 @default.
• W2922257911 citedByCount "7" @default.
• W2922257911 countsByYear W29222579112019 @default.
• W2922257911 countsByYear W29222579112021 @default.
• W2922257911 countsByYear W29222579112022 @default.
• W2922257911 countsByYear W29222579112023 @default.
• W2922257911 crossrefType "journal-article" @default.
• W2922257911 hasAuthorship W2922257911A5001066639 @default.
• W2922257911 hasAuthorship W2922257911A5012849300 @default.
• W2922257911 hasAuthorship W2922257911A5015556779 @default.
• W2922257911 hasAuthorship W2922257911A5040817479 @default.
• W2922257911 hasAuthorship W2922257911A5043647925 @default.
• W2922257911 hasAuthorship W2922257911A5061256789 @default.
• W2922257911 hasAuthorship W2922257911A5062178801 @default.
• W2922257911 hasAuthorship W2922257911A5062622461 @default.
• W2922257911 hasBestOaLocation W29222579112 @default.
• W2922257911 hasConcept C141071460 @default.
• W2922257911 hasConcept C142724271 @default.
• W2922257911 hasConcept C144133560 @default.
• W2922257911 hasConcept C2777106319 @default.
• W2922257911 hasConcept C512399662 @default.
• W2922257911 hasConcept C535046627 @default.
• W2922257911 hasConcept C71924100 @default.
• W2922257911 hasConceptScore W2922257911C141071460 @default.
• W2922257911 hasConceptScore W2922257911C142724271 @default.
• W2922257911 hasConceptScore W2922257911C144133560 @default.
• W2922257911 hasConceptScore W2922257911C2777106319 @default.
• W2922257911 hasConceptScore W2922257911C512399662 @default.
• W2922257911 hasConceptScore W2922257911C535046627 @default.
• W2922257911 hasConceptScore W2922257911C71924100 @default.
• W2922257911 hasFunder F4320308927 @default.
• W2922257911 hasFunder F4320332161 @default.
• W2922257911 hasIssue "3" @default.
• W2922257911 hasLocation W29222579111 @default.
• W2922257911 hasLocation W29222579112 @default.
• W2922257911 hasOpenAccess W2922257911 @default.
• W2922257911 hasPrimaryLocation W29222579111 @default.
• W2922257911 hasRelatedWork W1885025562 @default.
• W2922257911 hasRelatedWork W1887053995 @default.
• W2922257911 hasRelatedWork W1976756628 @default.
• W2922257911 hasRelatedWork W2081457677 @default.
• W2922257911 hasRelatedWork W2337969177 @default.
• W2922257911 hasRelatedWork W2400032093 @default.
• W2922257911 hasRelatedWork W2512276909 @default.
• W2922257911 hasRelatedWork W2766917267 @default.
• W2922257911 hasRelatedWork W2898581013 @default.
• W2922257911 hasRelatedWork W2156157633 @default.
• W2922257911 hasVolume "16" @default.
• W2922257911 isParatext "false" @default.
• W2922257911 isRetracted "false" @default.
• W2922257911 magId "2922257911" @default.
• W2922257911 workType "article" @default.